Therapy News and Research

RSS

New chemotherapy provides positive outcomes for hard-to-treat childhood cancers with few side-effects

Children with a particularly lethal cancer could benefit from potentially life-saving treatment, following breakthrough work led by researchers at the University of New South Wales (UNSW).

16 Aug 2013

Probiotic does not prevent clinical relapse in patients with Crohn's disease

Despite previous data showing beneficial effects, the probiotic Saccharomuces boulardii (S. boulardii) does not prevent clinical relapse in patients with Crohn's disease, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

16 Aug 2013

Joint symptoms in postmenopausal women not reduced by calcium and vitamin D supplements

A team of investigators systematically analyzed the effect of calcium and vitamin D supplementation on joint symptoms in a rigorous and controlled study of postmenopausal women.

16 Aug 2013

Sugar offers noninvasive way to precisely image tumors through new imaging technology

A natural form of sugar could offer a new, noninvasive way to precisely image tumors and potentially see whether cancer medication is effective, by means of a new imaging technology developed at UC San Francisco in collaboration with GE Healthcare.

16 Aug 2013

Researchers identify key mechanism behind aggressive prostate cancer

A team of researchers from UC Davis, UC San Diego and other institutions has identified a key mechanism behind aggressive prostate cancer. Published on August 14 in Nature, the study shows that two long non-coding RNAs (PRNCR1 and PCGEM1) activate androgen receptors, circumventing androgen-deprivation therapy.

16 Aug 2013

Children exposed to HIV in womb are no more likely to show language delays

Children who were exposed to HIV in the womb whose mothers received anti-HIV medications during pregnancy were no more likely to show language delays by age two than HIV-exposed children whose mothers were not treated during pregnancy, according to a study by University of Kansas Distinguished Professor Mabel L. Rice with researchers at the National Institutes of Health (NIH) and other universities.

16 Aug 2013

Preventive antibiotics for HIV patients lower risk of TB or death

As part of the largest international research effort ever made to combat tuberculosis, a team of Johns Hopkins and Brazilian experts has found that preventive antibiotic therapy for people with HIV lowers this group's chances of developing TB or dying.

16 Aug 2013

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.

15 Aug 2013

Johns Hopkins expert says crucial ethics should be considered in HIV cure research

A cure for HIV infection - the International AIDS Society meeting in Kuala Lumpur in early July offered new hope of the possibility, after researchers announced that two "Boston patients" had shown no resurgence of the virus after receiving a bone marrow transplant and ceasing their antiretroviral therapy (ART).

14 Aug 2013

Study shows enhancer RNA molecules may open new avenues for gene therapy

A study investigating the function of the recently discovered enhancer RNA molecules may open new avenues for gene therapy. According to the study researchers, altering the production and function of these molecules could affect the expression of genes and, in consequence, possibly also the progression of various diseases.

14 Aug 2013

Oraya Therapy Stereotactic Radiotherapy for treatment of wet AMDs now available at Optegra

Oraya Therapeutics, Inc. announced today that the Oraya Therapy Stereotactic Radiotherapy for the treatment of wet age-related macular degeneration (AMD) is now available at Optegra Manchester Eye Hospital, becoming the second facility in the UK to provide the therapy.

14 Aug 2013

"Risk calculator" enables doctors to estimate risk of venous thrombosis

In Austria, around 15,000 people a year develop a venous thrombosis, the occlusion of a vein that can result in a pulmonary embolism. A clot breaks free from a vein and travels via the bloodstream to the lungs, where it blocks vessels.

14 Aug 2013

Managing insulin levels through meal timing boosts ovulation in women with PCOS

Polycystic Ovarian Syndrome (PCOS), a common disorder that impairs fertility by impacting menstruation, ovulation, hormones, and more, is closely related to insulin levels. Women with the disorder are typically "insulin resistant" - their bodies produce an overabundance of insulin to deliver glucose from the blood into the muscles.

14 Aug 2013

Proton therapy provides organ-sparing treatment option for children with neuroblastoma

Proton therapy, using high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma. For patients in a new study of advanced radiation treatment, proton therapy spared the liver and kidneys from unwanted radiation, while zeroing in on its target.

14 Aug 2013

Administration delays health law's limit on some out-of-pocket consumer costs

The New York Times reports that the change was included in a Department of Labor rule issued in February. Also in the news, KHN details the complex choices the overhaul presents for people with disabilities and Bloomberg notes a ruling by a U.S. District Court judge allowing Oklahoma's legal challenge to the law to proceed.

14 Aug 2013

Researchers develop smartwatches to uncover reasons behind sleeping problems

Tonight will be another sleepless night for countless people, who will toss and turn for hours. And when they finally drift off, they will wake up with a start a short while later. If their disorder becomes chronic, sufferers often take part in medical sleep studies in an attempt to uncover the reasons behind their sleeping problems.

14 Aug 2013

PSA screening shows low-grade prostate cancers do not progress to higher grade over time

Prostate cancer aggressiveness may be established when the tumor is formed and not alter with time, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

14 Aug 2013

Virus-derived particles developed to kill human blood cancer cells, eradicate disease in mice

Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice with few side effects. The study is published in Blood Cancer Journal by co-senior authors Drs. David Conrad and John Bell of the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa).

14 Aug 2013

Study reveals cancer in humans linked with high amounts of proteins responsible for cells division

Cancer in humans is frequently associated with unusually high amounts of one or more proteins responsible for controlling the rate at which cells divide. As an example, excessive amounts of the cyclin-dependent kinase CDK6 are often found in types of cancer such as lymphoma.

14 Aug 2013

Clinical trials shows CRT improves symptoms, reduces mortality in patients with heart failure

In a large population of Medicare beneficiaries with heart failure who underwent implantation of a cardiac resynchronization therapy defibrillator, patients who had the cardiac characteristics of left bundle-branch block and longer QRS duration had the lowest risks of death and all-cause, cardiovascular, and heart failure readmission, according to a study in the August 14 issue of JAMA

14 Aug 2013

Therapy News and Research

New chemotherapy provides positive outcomes for hard-to-treat childhood cancers with few side-effects

Probiotic does not prevent clinical relapse in patients with Crohn's disease

Joint symptoms in postmenopausal women not reduced by calcium and vitamin D supplements

Sugar offers noninvasive way to precisely image tumors through new imaging technology

Researchers identify key mechanism behind aggressive prostate cancer

Children exposed to HIV in womb are no more likely to show language delays

Preventive antibiotics for HIV patients lower risk of TB or death

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Johns Hopkins expert says crucial ethics should be considered in HIV cure research

Study shows enhancer RNA molecules may open new avenues for gene therapy

Oraya Therapy Stereotactic Radiotherapy for treatment of wet AMDs now available at Optegra

"Risk calculator" enables doctors to estimate risk of venous thrombosis

Managing insulin levels through meal timing boosts ovulation in women with PCOS

Proton therapy provides organ-sparing treatment option for children with neuroblastoma

Administration delays health law's limit on some out-of-pocket consumer costs

Researchers develop smartwatches to uncover reasons behind sleeping problems

PSA screening shows low-grade prostate cancers do not progress to higher grade over time

Virus-derived particles developed to kill human blood cancer cells, eradicate disease in mice

Study reveals cancer in humans linked with high amounts of proteins responsible for cells division

Clinical trials shows CRT improves symptoms, reduces mortality in patients with heart failure

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News